Follow The Filings

BCRXBiocryst Pharmaceuticals Inc.

Q2 2023 13F holders among managers we track Latest ownership dossier

Ticker
BCRX
Type
Equity
Class
COM
Total reported value (long equity)
Manager Report date Value Shares